Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel

Creative Commons License

Algul E., Sunman H., Dural M., Guliyev I., Aker M., Felekoglu M. A., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.5, pp.1358-1365, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.3906/sag-1903-188
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1358-1365
  • Keywords: Acute coronary syndrome, atrial fibrillation, ticagrelor, P-WAVE DISPERSION, PULMONARY VEIN ISOLATION, MYOCARDIAL-INFARCTION, ENDOGENOUS ADENOSINE, EUROPEAN-SOCIETY, CARDIOPROTECTION, ELEVATION, THERAPY, HEART, ONSET
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background/aim: Ticagrelor is a drug widely used in patients with acute coronary syndromes (ACS) that specifically increases the plasma level of adenosine, which is likely to cause atrial fibrillation (AF). Therefore, in this study we aimed to investigate the electrocardiographic and echocardiographic predictors of AF development after P2Y12 receptor antagonists in ACS patients.